1968The Journal of Clinical Endocrinology & MetabolismRequires access

Suppression of Testosterone and Androstenedione Production Rates with Dexamethasone in Women with Idiopathic Hirsutism and Polycystic Ovaries

C. Wayne Bardin, Wylie C. Hembree, Mortimer B. Lipsett

Open publisher page 78 citations

Abstract

Testosterone and androstenedione plasma levels were measured in 7 normal women and 22 hirsute women with either idiopathic hirsutism (IH) or polycystic ovaries (PCO). During dexamethasone administration, plasma testosterone decreased 25% in normal subjects and 40–50% in the patients with IH and PCO. Plasma androstenedione levels were suppressed 40–55% in the normal and hirsute women. The mean testosterone metabolic clearance rate for 8 hirsute women increased 10 % during dexamethasone administration but there was no significant change in the androstpnedione metabolic clearance. Thus, the decrease in blood androgen levels produced by glucocorticoid was a consequence of decreased androgen production. These studies indicate further that a gland which is suppressed by dexamethasone is responsible for a significant fraction of the excess androgen production in women with either IH or PCO.

About this research paper

What this paper is about

Testosterone and androstenedione plasma levels were measured in 7 normal women and 22 hirsute women with either idiopathic hirsutism (IH) or polycystic ovaries (PCO). During dexamethasone administration, plasma testosterone decreased 25% in normal subjects and 40–50% in the patients with IH and PCO. Plasma androstenedione levels were suppressed 40–55% in the normal and hirsute women. The mean testosterone metabolic clearance rate for 8 hirsute women increased 10 % during dexamethasone administration but there was no significant change in the androstpnedione metabolic clearance. Thus, the decrease in blood androgen levels produced by glucocorticoid was a consequence of decreased androgen production. These studies indicate further that a gland which is suppressed by dexamethasone is responsible for a significant fraction of the excess androgen production in women with either IH or PCO.

Why it matters

OpenAlex reports 78 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Testosterone and androstenedione plasma levels were measured in 7 normal women and 22 hirsute women with either idiopathic hirsutism (IH) or polycystic ovaries (PCO). During dexamethasone administration, plasma testosterone decreased 25% in normal subjects and 40–50% in the patients with IH and PCO. Plasma androstenedione levels were suppressed 40–55% in the normal and hirsute women. The mean testosterone metabolic clearance rate for 8 hirsute women increased 10 % during dexamethasone administration but there was no significant change in the androstpnedione metabolic clearance. Thus, the decrease in blood androgen levels produced by glucocorticoid was a consequence of decreased androgen production. These studies indicate further that a gland which is suppressed by dexamethasone is responsible for a significant fraction of the excess androgen production in women with either IH or PCO.

Key concepts: Androstenedione, hirsutism, Endocrinology, Internal medicine, Polycystic ovary, Testosterone (patch), Dexamethasone, Androgen

Related papers

Back to paper searchBrowse research topicsOriginal source
Suppression of Testosterone and Androstenedione Production Rates with Dexamethasone in Women with Idiopathic Hirsutism and Polycystic Ovaries — Research Paper | ScholarLens